GlassScriptPhysician profile
Gregory R Polston
NPI 1891719233
$1,198.80
in general payments reported to CMS, 2019-2025
12 companies · $73.93 in 2025
The $73.93 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $205 · 2021: $248 · 2022: $410 · 2023: $52.80 · 2024: $76.91 · 2025: $73.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $382.36 | 2020-2025 | General - Pain Management |
| Grt US Holding, INC. | $221.43 | 2022 | |
| Abbott Laboratories | $176.72 | 2021-2024 | Eterna |
| Medtronic, INC. | $115.89 | 2022-2023 | Intellis Adaptivestim, Accurian |
| Nevro Corp. | $71.71 | 2019 | |
| Merz Pharmaceuticals, LLC | $48.64 | 2022 | |
| Relievant Medsystems, INC. | $40.48 | 2022 | |
| Medtronic USA, INC. | $39.91 | 2019 | |
| Merz North America, INC. | $34.73 | 2020 | |
| Lundbeck LLC | $24.09 | 2020 | |
| Avanos Medical | $22.52 | 2022 | |
| Tersera Therapeutics LLC | $20.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Polston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.